Evidence boundary No large Western randomized controlled trial of Pinealon has been published
F., Ganmaa, D., Bergman, P., Bischoff-Ferrari, H
Preclinical Research Dosing Models Animal model studies have explored GHK-Cu at the following ranges: Topical (in vitro/ex vivo): 10100 M concentrations in cell culture media Subcutaneous (rodent models): 15 mg/kg body weight, administered 12x daily Wound healing models: Local application at 110 g/wound site Reconstitution for Research GHK-Cu is typically supplied as a lyophilized powder
Long-term effects on follicle cycling (anagen, catagen, telogen transitions) were not assessed
Each capsule contains a blend of research compounds , including BPC-157 and TB-500 , and is supplied in a 60-capsule bottle , providing a standardized format suitable for controlled investigational and analytical research environments